BRPI0209172B8 - método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método - Google Patents

método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método

Info

Publication number
BRPI0209172B8
BRPI0209172B8 BRPI0209172A BR0209172A BRPI0209172B8 BR PI0209172 B8 BRPI0209172 B8 BR PI0209172B8 BR PI0209172 A BRPI0209172 A BR PI0209172A BR 0209172 A BR0209172 A BR 0209172A BR PI0209172 B8 BRPI0209172 B8 BR PI0209172B8
Authority
BR
Brazil
Prior art keywords
blood sample
test kit
individual
test
detecting gluten
Prior art date
Application number
BRPI0209172A
Other languages
English (en)
Other versions
BRPI0209172B1 (pt
BR0209172A (pt
Inventor
Korponay-Szabo Ilma
Mäki Markku
Original Assignee
Ilma Korponay Szabo
Markku Maeki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8561063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0209172(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ilma Korponay Szabo, Markku Maeki filed Critical Ilma Korponay Szabo
Publication of BR0209172A publication Critical patent/BR0209172A/pt
Publication of BRPI0209172B1 publication Critical patent/BRPI0209172B1/pt
Publication of BRPI0209172B8 publication Critical patent/BRPI0209172B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se

Abstract

"método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método". a invenção é direcionada a um método de detectar doenças induzidas por glúten, tais como, doença celíaca e dermatite herpetiforme. referidas doenças são indicadas pela presença de auto-anticorpos contra transglutaminase t<39>tg do tecido no sangue. o teste é realizado em uma amostra de sangue total (retirado de um doador) usando t<39>tg liberado das células do glóbulo vermelho (hemácia) da amostra sanguínea como um auto-antígeno. os auto-antígenos liberados reagem com os auto-anticorpos na amostra e formam complexos antígeno-anticorpo, os quais são detectados. a presença de tais complexos indica a doença. a invenção também é direcionada ao uso do auto-antígeno em um teste e em um kit de teste.
BRPI0209172A 2001-04-25 2002-04-24 método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método BRPI0209172B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010868A FI20010868A0 (fi) 2001-04-25 2001-04-25 Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
PCT/FI2002/000340 WO2002086509A1 (en) 2001-04-25 2002-04-24 Method and means for detecting gluten-induced diseases

Publications (3)

Publication Number Publication Date
BR0209172A BR0209172A (pt) 2004-08-03
BRPI0209172B1 BRPI0209172B1 (pt) 2017-06-06
BRPI0209172B8 true BRPI0209172B8 (pt) 2021-07-27

Family

ID=8561063

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0209172A BRPI0209172B8 (pt) 2001-04-25 2002-04-24 método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método

Country Status (11)

Country Link
US (1) US7361480B2 (pt)
EP (1) EP1390753B1 (pt)
AT (1) ATE412180T1 (pt)
BR (1) BRPI0209172B8 (pt)
CA (1) CA2445102C (pt)
DE (1) DE60229513D1 (pt)
ES (1) ES2314043T3 (pt)
FI (1) FI20010868A0 (pt)
HU (1) HU229679B1 (pt)
PL (1) PL208039B1 (pt)
WO (1) WO2002086509A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
GB0117870D0 (en) * 2001-07-21 2001-09-12 Univ Nottingham Trent Method of diagnosis and kit of parts therefor
GB0304993D0 (en) * 2003-03-05 2003-04-09 Univ Nottingham Trent Novel screening method
FR2857453B1 (fr) * 2003-07-11 2007-04-20 Covalab Procede de detection serologique de la maladie coeliaque et necessaire de diagnostic associe
ES2549481T3 (es) 2008-11-30 2015-10-28 Immusant, Inc. Composiciones y métodos para el tratamiento de enfermedad celíaca
US10449228B2 (en) 2013-09-10 2019-10-22 Immusant, Inc. Dosage of a gluten peptide composition
US10370718B2 (en) 2014-09-29 2019-08-06 Immusant, Inc. Use of HLA genetic status to assess or select treatment of celiac disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE461616B (sv) * 1987-05-08 1990-03-05 Biocarb Ab Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
WO1994020857A1 (en) * 1993-03-11 1994-09-15 The Regents Of The University Of California Assay for humoral immunity to macromolecules
DE19630557C2 (de) * 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
ATE269543T1 (de) * 1999-06-28 2004-07-15 Immundiagnostik Ag Diagnose der glutensensibilitätsenteropathie und anderer autoimmunerkrangungen
US6703208B1 (en) * 1999-10-20 2004-03-09 Immco Diagnostics Immunological assay for detection of antibodies in celiac disease
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Also Published As

Publication number Publication date
US7361480B2 (en) 2008-04-22
BRPI0209172B1 (pt) 2017-06-06
HUP0400066A2 (hu) 2004-04-28
US20040115750A1 (en) 2004-06-17
HU229679B1 (en) 2014-04-28
PL366996A1 (en) 2005-02-07
FI20010868A0 (fi) 2001-04-25
HUP0400066A3 (en) 2006-01-30
EP1390753A2 (en) 2004-02-25
CA2445102A1 (en) 2002-10-31
BR0209172A (pt) 2004-08-03
PL208039B1 (pl) 2011-03-31
ES2314043T3 (es) 2009-03-16
DE60229513D1 (de) 2008-12-04
CA2445102C (en) 2012-01-03
EP1390753B1 (en) 2008-10-22
WO2002086509A1 (en) 2002-10-31
ATE412180T1 (de) 2008-11-15
WO2002086509A8 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
Aslan et al. Lymphocyte DNA damage and oxidative stress in patients with iron deficiency anemia
AR107561A2 (es) Ensayo elisa para la detección de vegf
BRPI0410842B8 (pt) método in vitro para detecção da presença de um polinucleotídeo de psca em uma amostra teste derivada de um indivíduo como um indicador da presença de câncer
ATE435282T1 (de) Menschliche hämatopoietische stamm und vorläuferzellantigen und methoden zu dessen verwendung
BR0010068A (pt) Sistema de identificação do marcador fenotìpico e biológico
BR9912007A (pt) Composições e métodos para terapia e diagnóstico de câncer de próstata
DK1766400T3 (da) Fremgangsmåde til at udföre fuldblodsanalyser
BR9814007A (pt) Dispositivo de ensaio cromatográfico e processo para detectar a presença de um analito em uma amostra de sangue
MX2013008471A (es) Metodos y aparatos para la deteccion de sensibilidad al gluten y su diferenciacion de la enfermedad celiaca.
Khandelwal et al. CD38brightCD8+ T cells associated with the development of acute GVHD are activated, proliferating, and cytotoxic trafficking cells
BR0101294A (pt) Métodos de triagem de um composto que modula a atividade do canal de cálcio, e para bloqueadores e para estimuladores de icrac, kit para uso em um método, célula sanguìnea ou célula derivada do sangue, linfócito ou célula derivada de linfócito, ou mastócito ou célula derivada de mastócito, e, população de células imunes de roedores
DE59914830D1 (de) Verfahren und testbesteck zur beurteilung der oxid messung ihrer antiradikalen aktivität
BRPI0209172B8 (pt) método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método
WALDORF et al. Immunofluorescent studies in pemphigus vulgaris: Confirmatory observations and evaluation of technical considerations
ATE234467T1 (de) Immunoassay von vollblutproben
Quadeer et al. Epitopes targeted by T cells in convalescent COVID-19 patients
BR9808219A (pt) Processos de identificação e de isolamento de glóbulos vermelhos fetais ou embriÈnicos e de determinação de uma anormalidade fetal, kit de partes para determinação de uma anormalidade fetal e uso de uma unidade de ligação e de um meio
BR0211697A (pt) Marcador de câncer e usos deste na diagnose de câncer
CA2643158A1 (en) METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF HOST GRAFT REACTION BY MEASURING CD3 + CD4 + CD8.BETA. + CELLS IN PERIPHERAL BLOOD
Morales-González¹ et al. Nrf2 modulates cell proliferation and antioxidants defenses during liver regeneration induced by partial hepatectomy
AU5352901A (en) Method for quantification of akt protein expression
ES2107528T3 (es) Ensayos de la actividad de la amilina.
Pickering et al. In vitro FANCD2 monoubiquitination by HHR6 and hRad18
ES2733002T3 (es) Método para la detección mejorada de células inmunitarias específicas de antígeno que infiltran el tejido
Lanuti et al. A flow cytometry procedure for simultaneous characterization of cell DNA content and expression of intracellular protein kinase C-ζ

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/04/2002, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2719 DE 14-02-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.